Q-linea AB

Equities

QLINEA

SE0011527845

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm Other stock markets 11:29:41 2024-04-26 am EDT			5-day change	1st Jan Change
3.295 ^SEK	+64.91%		+59.56%	-10.95%

Mar. 13	Q-linea AB Presents Strong ASTar Results At AMCLI	CI
Feb. 27	Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024

Q-linea AB Receives First ASTar Order in France

July 27, 2023 at 03:00 am EDT

Q-linea AB (publ) announces that the company has received the first order for ASTar instruments and consumables from Eurobio Scientific in France. The instruments will be utilized at upcoming exhibitions and in future customer evaluations.

Latest news about Q-linea AB

Q-linea AB Presents Strong ASTar Results At AMCLI	Mar. 13	CI
Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Q-linea AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Q-linea AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Q-linea Presents at AMCLI	Feb. 15	CI
Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary	Feb. 09	MT
Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024	Feb. 01	CI
Q-linea Lands First ASTar Order from Finnish Distributor	Jan. 31	MT
Q-Linea AB Receives an Order for an ASTar System	Jan. 31	CI
Q-linea to Cut 40 Jobs in Cost Savings Program	Jan. 30	MT
Q-linea AB Announces CEO Changes	Jan. 22	CI
Q-linea AB Expands the Gram-Negative Panel	Jan. 17	CI
Q-Linea Wins Public Tender for Rapid AST	Jan. 15	CI
Q-linea Installs First ASTar Systems in US; Shares Jump	Dec. 28	MT
Q-linea Signs Distribution Deal for Benelux Region with Biomedical Diagnostics	Nov. 17	MT
Transcript : Q-linea AB, Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Q-linea AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Sweden's Q-linea Partners with Labema to Boost Presence in Finland, Baltic States	23-10-19	MT
Q-Linea AB Strengthens its Presence in Finland and the Baltics Through Partnership with Labema Oy	23-10-19	CI
Q-linea AB Receives Second ASTar Order in France	23-09-28	CI
Q-linea CEO Plans Retirement in 2024; Stock Tumbles 13%	23-09-07	MT
Q-Linea AB Announces Jonas Jarvius to Step Down as CEO Before Summer 2024	23-09-07	CI
Q-Linea AB Appoints Jonas Jarvius as A New Board Member in 2024	23-09-07	CI
Q-linea Shares Gain Amid Progress of French Distribution Deal	23-07-27	MT
Q-linea AB Receives First ASTar Order in France	23-07-27	CI

Chart Q-linea AB

Duration

Period

More charts

Company Profile

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-03 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Q-linea AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
Q-LINEA AB	-10.95%	35.11M
SARTORIUS AG	-12.91%	19.08B
QUIDELORTHO CORPORATION	-46.21%	2.65B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.15%	1.87B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.12%	1.61B
BIOTAGE AB	+23.78%	1.21B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.69%	1.02B
CONTEC MEDICAL SYSTEMS CO.,LTD	-20.89%	905M
REVENIO GROUP OYJ	-7.14%	716M
VAREX IMAGING CORPORATION	-18.10%	682M

Medical Diagnostic & Testing Equipment